355 related articles for article (PubMed ID: 37071471)
21. Clinical manifestations of clonal hematopoiesis: What has SF3B1-mutant MDS taught us?
Todisco G; Moura PL; Hellström-Lindberg E
Semin Hematol; 2022 Jul; 59(3):150-155. PubMed ID: 36115692
[TBL] [Abstract][Full Text] [Related]
22. Clonal Hematopoiesis of Indeterminate Potential Predicts Adverse Outcomes in Patients With Atherosclerotic Cardiovascular Disease.
Gumuser ED; Schuermans A; Cho SMJ; Sporn ZA; Uddin MM; Paruchuri K; Nakao T; Yu Z; Haidermota S; Hornsby W; Weeks LD; Niroula A; Jaiswal S; Libby P; Ebert BL; Bick AG; Natarajan P; Honigberg MC
J Am Coll Cardiol; 2023 May; 81(20):1996-2009. PubMed ID: 37197843
[TBL] [Abstract][Full Text] [Related]
23. Somatic Mutations and Clonal Hematopoiesis as Drivers of Age-Related Cardiovascular Risk.
Haring B; Wissel S; Manson JE
Curr Cardiol Rep; 2022 Aug; 24(8):1049-1058. PubMed ID: 35657494
[TBL] [Abstract][Full Text] [Related]
24. Clonal Hematopoiesis of Indeterminate Potential With Loss of
Lin AE; Bapat AC; Xiao L; Niroula A; Ye J; Wong WJ; Agrawal M; Farady CJ; Boettcher A; Hergott CB; McConkey M; Flores-Bringas P; Shkolnik V; Bick AG; Milan D; Natarajan P; Libby P; Ellinor PT; Ebert BL
Circulation; 2024 Apr; 149(18):1419-1434. PubMed ID: 38357791
[TBL] [Abstract][Full Text] [Related]
25. [Clonal hematopoiesis: causes and clinical implications].
Burchert A
Inn Med (Heidelb); 2022 Oct; 63(10):1051-1058. PubMed ID: 35969263
[TBL] [Abstract][Full Text] [Related]
26. Clonal hematopoiesis driven by mutated DNMT3A promotes inflammatory bone loss.
Wang H; Divaris K; Pan B; Li X; Lim JH; Saha G; Barovic M; Giannakou D; Korostoff JM; Bing Y; Sen S; Moss K; Wu D; Beck JD; Ballantyne CM; Natarajan P; North KE; Netea MG; Chavakis T; Hajishengallis G
Cell; 2024 May; ():. PubMed ID: 38838669
[TBL] [Abstract][Full Text] [Related]
27. Clonal hematopoiesis and cardiovascular disease: deciphering interconnections.
Stein A; Metzeler K; Kubasch AS; Rommel KP; Desch S; Buettner P; Rosolowski M; Cross M; Platzbecker U; Thiele H
Basic Res Cardiol; 2022 Nov; 117(1):55. PubMed ID: 36355225
[TBL] [Abstract][Full Text] [Related]
28. p53 involvement in clonal hematopoiesis of indeterminate potential.
Chen S; Liu Y
Curr Opin Hematol; 2019 Jul; 26(4):235-240. PubMed ID: 31045645
[TBL] [Abstract][Full Text] [Related]
29. A new risk factor associated with cardiovascular disease: clonal hematopoiesis of indeterminate potential.
Yu X; Qian N; Wang Y
Mol Biol Rep; 2023 Mar; 50(3):2813-2822. PubMed ID: 36595120
[TBL] [Abstract][Full Text] [Related]
30. CHIP-associated mutant ASXL1 in blood cells promotes solid tumor progression.
Liu X; Sato N; Shimosato Y; Wang TW; Denda T; Chang YH; Yabushita T; Fujino T; Asada S; Tanaka Y; Fukuyama T; Enomoto Y; Ota Y; Sakamoto T; Kitamura T; Goyama S
Cancer Sci; 2022 Apr; 113(4):1182-1194. PubMed ID: 35133065
[TBL] [Abstract][Full Text] [Related]
31. Clonal hematopoiesis: Genes and underlying mechanisms in cardiovascular disease development.
Haybar H; Shahrabi S; Ghanavat M; Khodadi E
J Cell Physiol; 2019 Jun; 234(6):8396-8401. PubMed ID: 30417440
[TBL] [Abstract][Full Text] [Related]
32. Diagnostic Challenge and Clinical Dilemma: The Long Reach of Clonal Hematopoiesis.
Osman A; Patel JL
Clin Chem; 2021 Aug; 67(8):1062-1070. PubMed ID: 34263288
[TBL] [Abstract][Full Text] [Related]
33. Clinical, Mutational, and Transcriptomic Characteristics in Elderly Korean Individuals With Clonal Hematopoiesis Driver Mutations.
Moon I; Kong MG; Ji YS; Kim SH; Park SK; Suh J; Jang MA
Ann Lab Med; 2023 Mar; 43(2):145-152. PubMed ID: 36281508
[TBL] [Abstract][Full Text] [Related]
34. Advances in understanding the molecular basis of clonal hematopoiesis.
Alagpulinsa DA; Toribio MP; Alhallak I; Shmookler Reis RJ
Trends Mol Med; 2022 May; 28(5):360-377. PubMed ID: 35341686
[TBL] [Abstract][Full Text] [Related]
35. Clonal Hematopoiesis of Indeterminate Potential (CHIP) and Incident Type 2 Diabetes Risk.
Tobias DK; Manning AK; Wessel J; Raghavan S; Westerman KE; Bick AG; Dicorpo D; Whitsel EA; Collins J; Correa A; Cupples LA; Dupuis J; Goodarzi MO; Guo X; Howard B; Lange LA; Liu S; Raffield LM; Reiner AP; Rich SS; Taylor KD; Tinker L; Wilson JG; Wu P; Carson AP; Vasan RS; Fornage M; Psaty BM; Kooperberg C; Rotter JI; Meigs J; Manson JE;
Diabetes Care; 2023 Nov; 46(11):1978-1985. PubMed ID: 37756531
[TBL] [Abstract][Full Text] [Related]
36. Early detection and intervention of clonal hematopoiesis for preventing hematological malignancies.
Ye B; Sheng Y; Zhang M; Hu Y; Huang H
Cancer Lett; 2022 Jul; 538():215691. PubMed ID: 35469959
[TBL] [Abstract][Full Text] [Related]
37. Mutant ASXL1 induces age-related expansion of phenotypic hematopoietic stem cells through activation of Akt/mTOR pathway.
Fujino T; Goyama S; Sugiura Y; Inoue D; Asada S; Yamasaki S; Matsumoto A; Yamaguchi K; Isobe Y; Tsuchiya A; Shikata S; Sato N; Morinaga H; Fukuyama T; Tanaka Y; Fukushima T; Takeda R; Yamamoto K; Honda H; Nishimura EK; Furukawa Y; Shibata T; Abdel-Wahab O; Suematsu M; Kitamura T
Nat Commun; 2021 Mar; 12(1):1826. PubMed ID: 33758188
[TBL] [Abstract][Full Text] [Related]
38. Association of Mutations Contributing to Clonal Hematopoiesis With Prognosis in Chronic Ischemic Heart Failure.
Dorsheimer L; Assmus B; Rasper T; Ortmann CA; Ecke A; Abou-El-Ardat K; Schmid T; Brüne B; Wagner S; Serve H; Hoffmann J; Seeger F; Dimmeler S; Zeiher AM; Rieger MA
JAMA Cardiol; 2019 Jan; 4(1):25-33. PubMed ID: 30566180
[TBL] [Abstract][Full Text] [Related]
39. Clonal Hematopoiesis and Premalignant Diseases.
Kaner J; Desai P; Mencia-Trinchant N; Guzman ML; Roboz GJ; Hassane DC
Cold Spring Harb Perspect Med; 2020 Apr; 10(4):. PubMed ID: 31615870
[TBL] [Abstract][Full Text] [Related]
40. Clonal Hematopoiesis and Its Impact on Human Health.
Ahmad H; Jahn N; Jaiswal S
Annu Rev Med; 2023 Jan; 74():249-260. PubMed ID: 36450282
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
